FindTrial
Sign In

Impella CP

DEVICE3 trials

Sponsors

Odense University Hospital, Assistance Publique Hopitaux De Marseille, Rayyan Hemetsberger

Conditions

Acute Myocardial InfarctionCardiogenic ShockCardiogenic Shock AcuteCoronary Artery DiseaseHeart Failure With Reduced Ejection Fraction

Unknown Phase

Danish Cardiogenic Shock Trial
CompletedNCT01633502
Odense University HospitalAcute Myocardial Infarction, Cardiogenic Shock Acute
Start: 2012-12-31End: 2024-04-30Updated: 2024-05-14
Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial
RecruitingNCT05366452
Assistance Publique Hopitaux De MarseilleCardiogenic Shock
Start: 2022-12-19End: 2026-12-31Target: 204Updated: 2023-01-25
STRATegy SUccesS in High-Risk PCI With Impella CP: Evaluation of Hemodynamic Protection in Complex PCI
Not yet recruitingNCT07588399
Rayyan HemetsbergerCoronary Artery Disease, Heart Failure With Reduced Ejection Fraction
Start: 2026-07-01End: 2027-10-01Target: 50Updated: 2026-05-27

Related Papers

Delay From First Symptoms in Patients Presenting With STEMI and Cardiogenic Shock: Insights From the DanGer Shock Trial.
2026-01-12
Systolic Blood Pressure and Microaxial Flow Pump-Associated Survival in Infarct-Related Cardiogenic Shock: A Post Hoc Analysis of the DanGer Shock Randomized Clinical Trial.
2025-11-011 citations
Sex-Specific Microaxial Flow Pump Use and Outcomes in Infarct-Related Cardiogenic Shock in the DanGer Shock Trial.
2025-10-17
Effect of Microaxial Flow Pump on Hemodynamics in STEMI-Related Cardiogenic Shock.
2025-07-014 citations
Treating Older Patients in Cardiogenic Shock With a Microaxial Flow Pump: Is it DANGERous?
2024-11-1517 citations
Abstract 4137009: Treating Elderly Cardiogenic Shock Patients with a Microaxial Flow Pump; Is It DANGERous?
Circulation2024-11-122 citations
Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial
Circulation2024-10-2734 citations
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock
JAMA Cardiology2024-10-2723 citations
Revolutionizing Cardiogenic Shock Treatment: Is the Microaxial Flow Pump the Ultimate Game Changer?
European Journal of Heart Failure2024-07-263 citations
Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock
New England Journal of Medicine2024-04-07652 citations
Rationale and design of the ULYSS trial: A randomized multicenter evaluation of the efficacy of early Impella CP implantation in acute coronary syndrome complicated by cardiogenic shock.
2023-08-307 citations
Danish-German cardiogenic shock trial-DanGer shock: Trial design update.
2022-10-1916 citations
Enrolling patients in cardiogenic shock trials: are we missing someone? Insights from the Italian AltShock‐2 registry
European Journal of Heart Failure2022-08-062 citations
Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.
2022-04-1857 citations
Long-Term Clinical Outcome of Cardiogenic Shock Patients Undergoing Impella CP Treatment vs. Standard of Care
Journal of Clinical Medicine2020-11-2424 citations